On this page
Back to topLumexa Imaging Holdings LMRI
Lumexa Imaging Holdings listed on Nasdaq on 12 Dec 2025 and is not in the S&P 500. It is worth $1.4 billion. Its price history starts on 12 Dec 2025. Its board has 9 directors, 6 of them independent. 3 other officers are on file. At 30 Jun 2026, Brown Advisory was its largest institutional holder, with 6.0% of the company.
- CEO
- Caitlin Zulla
- Chair
- Henry Lee Cooper
- Listed
- 12 Dec 2025 on Nasdaq, IPO filings and terms
- Headquarters
- Raleigh, NC
- Market cap
- $1.4B
- 19 Nov 2026 close
- Revenue
- -
- No annual report yet
Financials
Financial history
Twelve months to 30 Sep 2026, from Lumexa Imaging Holdings' quarterly filings.
Quarters since Mar 2025
- P/E
- -
- No profit over the last four quarters
Quarterly results
Each quarter's revenue, net income and free cash flow.
Mar 2025 to Sep 2026
| Quarter | Revenue | Net income |
|---|---|---|
| Sep 2026 | $272M | $7M |
| Jun 2026 | $264M | $3M |
| Mar 2026 | $253M | $2M |
| Sep 2025 | $259M | $-4M |
| Jun 2025 | $251M | $-7M |
| Mar 2025 | $245M | $-8M |
Revenue breakdown
Lumexa Imaging Holdings' $272M of revenue, as its quarterly report splits it. Parts that are not a business, such as sales between segments, can be negative.
Quarter to Sep 2026
| Split by | Part | Revenue |
|---|---|---|
| Segment | Outpatient | $202M |
| Segment | Professional | $74M |
| Segment | Intersegment Eliminations | -$4M |
| Product | Health Care Patient Service | $202M |
| Product | Management Fee And Other Revenue Related Party | $53M |
| Product | Patient Service Revenue Related Party | $9M |
| Product | Investment Advisory Management And Administrative Service | $8M |
Lumexa Imaging Holdings' market cap since December 2025
Weekly, up to 13 Nov 2026
| Week ending | Market cap |
|---|---|
| 13 Nov 2026 | $1.4B |
| 26 Dec 2025 | $1.7B |
Download Lumexa Imaging Holdings' data as JSON, with the weekly market caps in billions of dollars from 12 Dec 2025.
Board and leadership
Board and officers
3 people here also hold roles at other S&P 500 companies.
Board from the proxy filed 28 Apr 2026; officers filed up to 30 Sep 2026
| Name | Title | Since | Independent | Committees | Age |
|---|---|---|---|---|---|
| Directors (9) | |||||
| Henry Lee CooperChairNot independent 路 since 2025Chief Executive Officer, AssistRx, LLC | |||||
| Caitlin ZullaChief Executive OfficerNot independent 路 since 2025Other boards: National Vision Holdings | |||||
| Brett BrodnaxDirectorIndependent 路 since 2025 路 Compensation (chair), Nominating and Corporate Governance, Patient Safety and Quality of CareExecutive Chairman, United Surgical Partners International, Inc. | |||||
| Glenn A. EisenbergDirectorIndependent 路 since 2025 路 Audit (chair), CompensationSpecial Advisor, Labcorp Holdings Inc.Also at SolventumOther boards: Middleby and MiniMed Group | |||||
| Molly JosephLead Independent DirectorIndependent 路 since 2025 路 Audit, Nominating and Corporate Governance (chair)Managing Partner, Cypress Pass Ventures, LLCAlso at West Pharmaceutical Services | |||||
| Bridget E. KarlinDirectorIndependent 路 since 2025 路 Audit, Technology (chair)Managing Director, BEK Strategies, Inc.Also at LyondellBasellOther boards: Dana | |||||
| Matthew LungrenDirectorIndependent 路 since 2025 路 Patient Safety and Quality of Care (chair), TechnologyAdjunct Professor at Stanford and Clinical Associate Professor and practicing interventional radiologist at UCSF | |||||
| Robert Louis Mittl Jr.DirectorNot independent 路 since 2025 路 Patient Safety and Quality of Care, TechnologyPracticing neuroradiologist | |||||
| Brian Thomas ReganDirectorIndependent 路 since 2025 路 Compensation, Nominating and Corporate GovernanceGeneral Partner, Welsh, Carson, Anderson & Stowe | |||||
| Officers (3) | |||||
| James Anthony MartinChief Financial OfficerLast filed 15 Jan 2026 | |||||
| Russell StewartChief Medical OfficerLast filed 16 Dec 2025 | |||||
| James Edward Walker Jr.Principal Accounting OfficerLast filed 27 Feb 2026 | |||||
Owners and trading
Largest institutional holders
Each fund group's share of Lumexa Imaging Holdings. Where a company has several share classes, the share is of its total value.
13F filings for the quarter to 30 Jun 2026
Insider trades
Open-market buys and sales by directors and officers. Grants, option exercises and shares withheld for tax are left out.
Trades from 19 Nov 2025 to 19 Nov 2026
Directors and officers made no open-market sales and bought $476,950 in 2 purchases in the 12 months to 19 Nov 2026.
| Date | Person | Value |
|---|---|---|
| 19 May 2026Buy | Brett BrodnaxDirector | $254K |
| 14 May 2026Buy | Henry Lee CooperChair | $223K |
Timeline
Leadership changes, layoffs and insider sales
20 Nov 2024 to 20 Nov 2026; insider sales from 19 Nov 2025
1 departure and 4 appointments of directors and officers in the last two years.
Events, newest first
- 12 Jan 2026 Julie Szeker resignedChief Legal Officer and Corporate Secretary, effective 13 Mar 2026
- 12 Dec 2025 Robert Mittl appointedDirector, effective 10 Dec 2025
- 12 Dec 2025 Matthew Lungren appointedDirector, effective 10 Dec 2025
- 12 Dec 2025 Bridget Karlin appointedDirector, effective 10 Dec 2025
- 12 Dec 2025 Brett Brodnax appointedDirector, effective 10 Dec 2025
| Date | Event | Filing |
|---|---|---|
| 12 Jan 2026 | Julie Szeker resignedChief Legal Officer and Corporate Secretary, effective 13 Mar 2026 | 8-K |
| 12 Dec 2025 | Robert Mittl appointedDirector, effective 10 Dec 2025 | 8-K |
| 12 Dec 2025 | Matthew Lungren appointedDirector, effective 10 Dec 2025 | 8-K |
| 12 Dec 2025 | Bridget Karlin appointedDirector, effective 10 Dec 2025 | 8-K |
| 12 Dec 2025 | Brett Brodnax appointedDirector, effective 10 Dec 2025 | 8-K |
Not on file: no trades disclosed by members of Congress or officials since November 2023, no WARN layoff notices under its own name or a listed subsidiary's since November 2023, no open roles from its careers site yet and no earnings release figures from the last six months.